ACELG

Archives for Commission

What did we learn from the BSE crisis? Remember how the European Commission was criticised for letting market concerns take precedence over public health protection? With the ongoing reshuffling of the Commission portfolios by President-elect Juncker, some major units for EU public health protection, such as ‘Health Technology and Cosmetics’, ‘Medicinal Products – Authorisations, European… » read more

Posted by acelg

The demand to transfer powers from the EU back to the national level is politically en-vogue in several EU Member States at the moment. EU policy on agricultural biotechnology, however, is an interesting exception. The Council of Ministers has recently deadlocked[1] a Commission legislative proposal to re-nationalise parts of EU legislation on the cultivation of… » read more

Posted by acelg

The Commission’s Second Report concerning the application of the Directive on injunctions for the protection of consumers’ interest was recently published. While the publication of the report went rather unnoticed it does merit a short comment for the following reason. The report illustrates well how the Commission’s general policy is developing with regard to consumer… » read more

Posted by acelg

Dalligate tests the European Parliament’s oversight over the Commission. By Maarten Hillebrandt A few weeks ago, the European institutions were shaken by a series of events which, at first sight, could constitute the plot of an institutional thriller. On 16 October, after an investigation into allegations of corruption conducted by the European Anti-Fraud Office (OLAF),… » read more

Posted by acelg

A draft proposal from the Commission to amend Directives 2009/30/EC and 2009/28/EC seems to attest a radical change in the promotion of biofuels in the European market, one of the most controversial fields of EU policy. The draft, leaked earlier in September, aims to address the adverse effects on food prices and land-use change resulting… » read more

Posted by acelg